Phase 1 Mesothelioma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with advanced cancer that produces a specific protein called GPC3 or Mesothelin.
- Doctors expect you to live for more than 12 weeks.
- Your heart, lungs, liver, kidneys, and blood are working well enough to meet the trial's health requirements.
- A special batch of your own immune cells (called CAR-T cells) has been successfully prepared in the lab and meets the required performance standards for this trial.
- You (or your legal guardian) have read, understood, and signed a consent form agreeing to take part.
Who may not be able to join:
- You have previously received gene therapy of any kind.
- You have a serious viral infection, such as hepatitis B (HBV), hepatitis C (HCV), or HIV.
- You have tested positive for HIV.
- You currently have an active infection caused by bacteria, a virus, a fungus, or similar (confirm with trial site).
- You have another serious illness that the trial doctors feel makes participation unsuitable.
- You are currently pregnant or breastfeeding.
- You are taking regular steroid medication at a dose of 0.5 mg or more of prednisone (or an equivalent drug) per kilogram of body weight per day.
- There are other health or personal reasons that the trial doctors believe make participation unsuitable (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Zhenfeng Zhang, MD, PhD, Second Affiliated Hospital of Guangzhou Medical University
Phone: 0086-020-39195965
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Number of Patients with Dose Limiting Toxicity
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.